Table 3.
Correlation analysis in functionally different MNV subgroups (VT cutoff 8.40).
| Low-high MNV VT subgroups | Parameter | Speckled fluorescence (quadrants) | MNV area/leakage area ratio | Baseline BCVA | Final BCVA | Intravitreal injection number |
|---|---|---|---|---|---|---|
| Tau Kendall coeff. | 0.356 | 0.299 | −0.322 | 0.290 | −0.449 | |
| p | <0.001 | =0.003 | =0.002 | =0.006 | <0.001 | |
| Low-high MNV VT subgroups | Parameter | MNV VT | Baseline CMT | Final CMT | VD DCP | |
| Tau Kendall coeff. | 0.700 | −0.343 | −0.291 | −0.283 | ||
| p | <0.001 | <0.008 | =0.01 | =0.005 | ||
| MNV type (Type 1, Mixed, Type 2) | Parameter | MNV area | MNV area/leakage area ratio | Baseline CMT | Final CMT | |
| Tau Kendall coeff. | −0.319 | −0.373 | 0.377 | 0.273 | ||
| p | =0.004 | =0.002 | <0.001 | =0.006 | ||
| Leakage area | Parameter | MNV Area | VD CC | |||
| Tau Kendall coeff. | 0.705 | −0.281 | ||||
| p | <0.001 | =0.003 | ||||
| MNV area | Parameter | VD CC | ||||
| Tau Kendall coeff. | −0.250 | |||||
| p | =0.003 | |||||
| MNV area/leakage area ratio | Parameter | Intravitreal injection number | MNV VT | Baseline CMT | Final CMT | VD DCP |
| Tau Kendall coeff. | −0.337 | 0.346 | −0.336 | −0.291 | −0.257 | |
| p | =0.008 | <0.001 | <0.001 | =0.004 | =0.005 | |
| MNV VT | Parameter | Baseline exudation | Baseline CMT | Final CMT | VD DCP | |
| Tau Kendall coeff. | −0.326 | −0.256 | −0.303 | −0.297 | ||
| p | =0.009 | =0.002 | =0.004 | =0.005 | ||
| VD DCP | Parameter | Speckled fluorescence (quadrants) | Baseline exudation | Final exudation | Baseline CMT | Final CMT |
| Tau Kendall coeff. | −0.241 | 0.198 | 0.315 | 0.246 | 0.296 | |
| p | =0.004 | =0.008 | =0.005 | =0.004 | =0.004 |
MNVs were divided in accordance with a VT cutoff value of 8.40. MNV, macular neovascularization; BCVA, best-corrected visual acuity; CMT, central macular thickness; VT, vessel tortuosity; VD, vessel density; DCP, deep capillary plexus; CC, choriocapillaris.